HCW Biologics earned upfront payment and will recognize revenue of $7.0 million in Q2 2025MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombi ...

Core Viewpoint - Theon International Plc has successfully completed a share placement, increasing its free float to enhance liquidity and attract investor interest [2][3][4]. Group 1: Share Placement Details - Venetus Limited sold approximately 3.73 million shares, representing about 5.3% of Theon's share capital, with the placement priced at Euro 31.1 per share [2][4]. - Theon will not receive any proceeds from this placement, which was executed to improve the liquidity of its shares [3][4]. - Following the placement, Venetus and CHRE Investment Limited will hold approximately 70.0% of the company's share capital, while the free float will increase to 30.0% [4]. Group 2: Market Response and Future Outlook - The placement was oversubscribed, indicating strong interest from both existing and new investors, with demand nearly double that of a previous placement [6]. - The CEO expressed confidence that the increased free float will enhance trading liquidity and support the company's long-term growth strategy [6]. Group 3: Company Background - Theon Group specializes in developing and manufacturing advanced night vision and thermal imaging systems for defense and security applications, with a global presence [8]. - The company has over 200,000 systems in service across 71 countries, including 26 NATO member countries, and has been listed on Euronext Amsterdam since February 2024 [8].

Core Insights - Comscore has expanded its partnership with ShowSeeker to integrate person-level local live and DVR data into the Pilot platform, enhancing audience evaluation and transaction capabilities for media buyers and sellers [1][2][3] Group 1: Partnership and Integration - The integration allows for person-level insights combined with local time-shifted viewing data, marking a significant advancement in local market measurement and campaign execution [2] - This collaboration enables users to assess individual-level demographics, such as age and gender, rather than just household-level impressions [2][3] Group 2: Benefits to Users - The integration enhances the ability to build proposals, evaluate schedules, and measure campaign performance within a platform tailored for media buyers and sellers [3] - Users can expect improved targeting precision, proposal automation, and post-campaign analysis as a result of this update [4] Group 3: Company Backgrounds - Comscore is recognized as a trusted partner for planning, transacting, and evaluating media across various platforms, providing comprehensive cross-platform measurement [5] - ShowSeeker, founded in 2003, offers cloud-based campaign management solutions, streamlining the advertising sales lifecycle and maximizing ROI for clients [6]

Core Viewpoint - Alpha Modus Holdings, Inc. is enhancing its capital structure by converting Series C Preferred Stock into Class A Common Stock, which is expected to increase shareholder equity by $31 million [1][2][3] Group 1: Financial Impact - The transaction will remove approximately $31 million in preferred equity obligations from the mezzanine section of the balance sheet, improving long-term solvency metrics and reducing perceived risk [2][8] - The conversion will increase common stock by 26,515,152 shares and $2,651, while additional paid-in capital will rise by $31,148,742, boosting the company's permanent equity base [8] Group 2: Strategic Implications - The move is described as a structural upgrade that aligns the interests of the CEO's family with common shareholders, signaling a commitment to growth rather than debt [3][8] - By reducing mezzanine equity and increasing common equity, the company aims to enhance its attractiveness to institutional investors and improve investor transparency [8] Group 3: Company Mission - Alpha Modus remains focused on driving shareholder value through patent enforcement, AI technology adoption, and strategic expansion in the retail innovation sector [4]

Core Viewpoint - FOXO Technologies Inc. has executed an agreement to issue 1,650 shares of Series A Cumulative Convertible Redeemable Preferred Stock for net proceeds of $1,500,000, indicating a strategic move to enhance its financial position and support growth initiatives [1][2]. Financial Summary - The issuance of Series A Preferred Stock is expected to generate gross proceeds of $1,650,000, with the company agreeing to pay investor costs of $150,000 [2]. - The first closing of this transaction occurred on June 4, 2025, with subsequent closings planned based on the effective date of a registration statement [2]. - In the first quarter of 2025, FOXO reported over $3 million in net revenues and a $4.4 million improvement in stockholders' equity, bringing total stockholders' equity to $9.7 million as of March 31, 2025, compared to a negative $17.5 million as of September 30, 2024 [3]. Company Overview - FOXO Technologies operates three subsidiaries: Rennova Community Health, which runs a critical access hospital in East Tennessee; Myrtle Recovery Centers, a behavioral health facility; and FOXO Labs, a biotechnology company focused on health and lifespan improvement through innovative technology [4][5].

Core Insights - K Wave Media, Inc. aims to become "the Metaplanet of Korea," inspired by Japan's Metaplanet Inc., which achieved a return of over 4,000% in 2024 [1][3] - The company has entered a securities purchase agreement to sell up to $500 million of ordinary shares to support its Bitcoin-centric digital asset treasury strategy and expand its K-POP related businesses [1][2] Financial Strategy - Proceeds from the share sale will be allocated to purchasing, long-term holding, and yield optimization of Bitcoin (BTC), positioning K Wave as one of the first publicly traded media companies to integrate BTC into its treasury operations [2][4] - The company plans to operate Bitcoin Lightning Network nodes and invest in Bitcoin-native infrastructure to enhance decentralization and facilitate on-chain transaction rewards [2][4] Business Model and Vision - K Wave's strategy reflects a commitment to innovation and forward-looking asset management by adopting Bitcoin as its core reserve asset, aiming to strengthen its balance sheet and align with the growing global Bitcoin economy [4][6] - The integration of BTC into K Wave's operations is expected to enhance consumer experiences in a WEB3 environment, allowing for KWM's content and K-POP merchandising to be purchased using BTC [3][6] Leadership Commentary - The Chairman of the Board emphasized that K Wave's adoption of Bitcoin as a treasury reserve asset signals the convergence of digital media and decentralized finance, aiming to create long-term value for shareholders [4] - The Co-Interim CEO highlighted that embedding BTC into the company's core strategy reinforces its commitment to decentralization and innovation, positioning K Wave to expand within the K-POP ecosystem [4][6] Company Overview - K Wave Media Ltd, founded in 2023 and headquartered in the Cayman Islands, focuses on producing high-quality K-content and K-POP merchandising while integrating blockchain technology [7] - The company aims to redefine the intersection of entertainment, technology, and finance by building an ecosystem that supports decentralized ownership and real-time creator monetization [7]

Designation Supported by CLOVER WaM Phase 2 Study DataWhich Reported an 83.6% Overall Response Rate (ORR) Seeking Guidance from EMA to Determine if CLOVER WaM Phase 2 Data Meets Criteria to Apply for Fast-Track, Conditional Marketing Authorization, Answer Expected Late July FLORHAM PARK, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announ ...

New office deepens partnership with the National Pension Service and strengthens presence in KoreaJEONJU, South Korea, June 04, 2025 (GLOBE NEWSWIRE) -- StepStone Group (Nasdaq: STEP), a global private markets solutions provider, has opened an office in Jeonju, North Jeolla Province, South Korea. The new office marks a continued expansion of StepStone’s long-standing relationship with the National Pension Service (NPS), one of the world’s largest institutional investors. This is StepStone’s second office in ...

Projects in Florida, Rhode Island, and California will have a combined capacity of nearly 3 MW upon completion FREMONT, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that IQ8P-3P™ Commercial Microinverters made with domestic content were selected for significant commercial projects on a Florida school, an affordable housing complex in Rhode Is ...

Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS) assessment at 12 weeks. Efzofitimod was generally safe and well tolerated at all doses. SAN DIEGO, June 04, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in- class medicines from its proprietary tRNA synthetase platform, today announc ...